It is premature to change the approved dosage and schedule of vaccines, the Food and Drug Administration of the US Department of Health and Human Services said.
The Food and Drug Administration of the US Department of Health and Human Services (FDA) considers it premature to reduce coronavirus vaccination dosage. This is stated in a statement issued by the regulator.
“We monitor discussions and reports about reducing the number of doses, the time interval between use, changing the dose (half the dose) or mixing drugs to vaccinate more people. These are reasonable questions that require consideration and evaluation during clinical trials, – stated in the text. “At the moment, it is premature to change the dosages and schedule of vaccines approved by the department; the available information does not justify this.”
According to the department representatives, without the availability of relevant information, the introduction of changes poses a risk to public health.
American immunologist Moncef Slaoui, who heads a team of scientists who participate in the state program for the development and distribution of the vaccine, said in an interview with CBS on January 3 that the authorities are discussing the possibility of using only half a dose of the Moderna drug in vaccination to speed up the process and increase coverage of the population.